Palbociclib Combined With an Aromatase Inhibitor in Breast Cancer
Condition(s):Breast CancerLast Updated:July 20, 2021Unknown status
Hide Studies Not Open or Pending
Condition(s):Breast CancerLast Updated:July 20, 2021Unknown status
Condition(s):Triple Negative Breast Cancer (TNBC)Last Updated:November 18, 2023Recruiting
Condition(s):Breast Cancer; Other Disorders of Bone Density and StructureLast Updated:September 20, 2016Completed
Condition(s):Breast Cancer FemaleLast Updated:December 16, 2016Unknown status
Condition(s):Neoplasms, BreastLast Updated:May 25, 2021Terminated
Condition(s):Breast CancerLast Updated:February 21, 2023Completed
Condition(s):Breast CancerLast Updated:November 8, 2016Terminated
Condition(s):Stages II-III Breast CancerLast Updated:March 31, 2017Terminated
Condition(s):Breast CancerLast Updated:October 25, 2016Completed
Condition(s):Breast CancerLast Updated:August 13, 2018Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.